Researchers led by Eduardo Marbón of the Cedars-Sinai Heart Institute have developed a method to prolong the lives of patients with Duchenne Muscular Dystrophy [DMD] through the infusion of cardiac stem cells. The stem cells reverse the loss of cardiac muscle caused by the genetic disease, preventing heart failure that would otherwise limit a patient’s life expectancy to age 25.
While stem cells have been integral to researching DMD’s genetic component and effect on skeletal muscle, this Cedars Sinai study is the first to address the actual cause of death for patients, which is the heart failure caused by the degeneration of cardiac muscle. With the initial success of pre-clinical trials, Dr. Marbón is hopeful that stem cells can provide duchenne muscular dystrophy patients with longer, healthier lives.
Dr. Marbón’s research is an example of the potential for stem cell regenerative medical therapies to effectively treat seemingly intractable and incurable conditions. To learn more about stem cells and how to insure immediate access to emerging personalized regenerative treatments by banking your own valuable stem cells, please visit StemSave or call 877-783-6728 (877- StemSave) today.
To view the full article, click here
The Future of Regenerative Medicine is Now™.